Usefulness of Cardiac Resynchronization Therapy in the Management of Doxorubicin-Induced Cardiomyopathy

American Journal of Cardiology

Volumn 101, Issue 9, 2008, Pages 1371-1372

  Ajijola, Olujimi A ^a   Nandigam, K Veena ^a   Chabner, Bruce A ^a   Orencole, Mary ^a   Dec, G William ^a   Ruskin, Jeremy N ^a   Singh, Jagmeet P ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ATORVASTATIN; CARVEDILOL; DIGOXIN; DILTIAZEM; DOXORUBICIN; ENALAPRIL; FUROSEMIDE; ISOSORBIDE MONONITRATE; LISINOPRIL; METOPROLOL SUCCINATE; METOPROLOL TARTRATE; QUINAPRIL; SPIRONOLACTONE; TORASEMIDE;

ADULT; ARTICLE; BASAL CELL CARCINOMA; BREAST CARCINOMA; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CASE REPORT; CLINICAL TRIAL; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HODGKIN DISEASE; HUMAN; LARGE CELL LYMPHOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

ADULT; ANTINEOPLASTIC AGENTS; CARDIOMYOPATHY, DILATED; DEFIBRILLATORS, IMPLANTABLE; DOXORUBICIN; FEMALE; HUMANS; MIDDLE AGED; PROGNOSIS; TREATMENT OUTCOME;

EID: 43049141462     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.12.037     Document Type: Article

References (6)

1. Gatta G., Capocaccia R., Coleman M.P., Ries L.A., and Berrino F. Childhood cancer survival in Europe and the United States. Cancer 95 (2002) 1767-1772
2. Minotti G., Menna P., Salvatorelli E., Cairo G., and Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56 (2004) 185-229
3. Keefe D.L. Anthracycline-induced cardiomyopathy. Semin Oncol 28 suppl (2001) 2-7
4. Singal P.K., and Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med 339 (1998) 900-905
5. Felker G.M., Thompson R.E., Hare J.M., Hruban R.H., Clemetson D.E., Howard D.L., Baughman K.L., and Kasper E.K. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 342 (2000) 1077-1084
6. Steinherz L., Steinherz P., Tan C.T., Heller G., and Murphy M.L. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA 266 (1991) 1672-1677